JOURNEY II
Device
Smith+Nephew, Inc.
Total Payments
$19.0M
Transactions
5,542
Doctors
1,389
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $5.6M | 1,832 | 476 |
| 2023 | $5.2M | 1,089 | 455 |
| 2022 | $5.9M | 1,761 | 588 |
| 2021 | $1.3M | 626 | 303 |
| 2020 | $992,061 | 234 | 112 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $12.6M | 327 | 66.7% |
| Unspecified | $2.3M | 139 | 12.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.7M | 425 | 8.9% |
| Consulting Fee | $1.3M | 427 | 6.8% |
| Travel and Lodging | $759,826 | 1,381 | 4.0% |
| Food and Beverage | $228,320 | 2,818 | 1.2% |
| Space rental or facility fees (teaching hospital only) | $32,758 | 7 | 0.2% |
| Debt forgiveness | $24,198 | 10 | 0.1% |
| Education | $1,706 | 8 | 0.0% |
Payments by Type
General
$16.7M
5,403 transactions
Research
$2.3M
139 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Establishment of implant outcomes data registry | Smith+Nephew, Inc. | $897,141 | 0 |
| In Vivo Kinematic Analysis of Cruciate Retaining, Posterior Cruciate Substituting and ACL-PCL Retaining Bi-Cruciate Total Knee Arthroplasty | Smith+Nephew, Inc. | $452,028 | 0 |
| A Critical Assessment of the Factors That Promote or Limit the Return to Recreational, Work, and Physical Fitness Activities after Primary Total Knee Arthroplasty | Smith+Nephew, Inc. | $132,734 | 0 |
| Data Capture relating to JII Uni for Unicompartmental Knee Arthroplasty | Smith+Nephew, Inc. | $89,120 | 0 |
| Data Capture relating to S&N Orthopaedics Products | Smith+Nephew, Inc. | $71,856 | 0 |
| Data Capture relating to the JOURNEY II UK KNEE SYSTEM | Smith+Nephew, Inc. | $63,475 | 0 |
| Follow-Up of Subjects with a Journey UNI Unicompartmental Knee System Implant | Smith+Nephew, Inc. | $42,382 | 0 |
| A Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate the Outcomes of Total Knee Arthroplasty TKA Using JOURNEY II BCS Total Knee System The NIMBLE study | Smith+Nephew, Inc. | $40,952 | 0 |
| Data Capture relating to Journey II CR Total Knee System | Smith+Nephew, Inc. | $38,688 | 0 |
| A Prospective, Multicenter Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey II UNI Unicompartmental Knee System | Smith+Nephew, Inc. | $33,900 | 0 |
| A Prospective, Non-randomized, Single Cohort, Multicenter Study to Evaluate the Clinical Outcomes of Total Knee Arthroplasty TKA Using the JOURNEY II CR Total Knee System | Smith+Nephew, Inc. | $32,960 | 0 |
| Safety and Performance of Journey II Cruciate Retaining Total Knee System: A Retrospective, Multicenter Study | Smith+Nephew, Inc. | $12,045 | 0 |
| Data Capture Relating to JOURNEY II UNI | Smith+Nephew, Inc. | $10,000 | 0 |
| Short-term performance of the Journey II Unicompartmental Arthroplasty: An early review of clinical efficacy | Smith+Nephew, Inc. | $9,500 | 0 |
| Data Capture relating to JOURNEY II CR with Deep Dish Insert | Smith+Nephew, Inc. | $2,575 | 0 |
| Journey II BCS Safety and Efficacy Study | Smith+Nephew, Inc. | $2,100 | 0 |
| Journey II BCS Safety and Efficacy Study an Advanced Bi-Cruciate stabilized total knee implant | Smith+Nephew, Inc. | $334.00 | 0 |
Top Doctors Receiving Payments for JOURNEY II
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Adult Reconstructive Orthopaedic Surgery | Reno, NV | $3.6M | 49 |
| Unknown | — | Philadelphia, PA | $3.5M | 182 |
| , M.D | Orthopaedic Surgery | New York, NY | $3.0M | 96 |
| , MD | Orthopaedic Surgery | Malvern, PA | $2.6M | 24 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Plano, TX | $434,674 | 40 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Arlington, VA | $395,556 | 84 |
| , MD | Orthopaedic Surgery | New York, NY | $386,872 | 94 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Chicago, IL | $289,543 | 53 |
| , MD | Orthopaedic Surgery | Santa Monica, CA | $238,336 | 24 |
| , M.D | Orthopaedic Surgery | New York, NY | $231,038 | 46 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Charlotte, NC | $206,214 | 29 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | La Jolla, CA | $193,949 | 28 |
| , M.D., PH.D | Adult Reconstructive Orthopaedic Surgery | Durham, NC | $186,597 | 65 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $183,913 | 14 |
| James Wood | Orthopaedic Surgery | Baltimore, MD | $183,556 | 11 |
| , M.D | Orthopaedic Surgery | New York, NY | $182,970 | 15 |
| , M.D., M.SC | General Acute Care Hospital | Orange, CA | $177,624 | 83 |
| , MD | Orthopaedic Surgery | Salisbury, NC | $125,286 | 90 |
| , MD | Orthopaedic Surgery | Aurora, IL | $123,444 | 69 |
| , D.O | Adult Reconstructive Orthopaedic Surgery | Kenosha, WI | $94,454 | 91 |
| , M.D | Student in an Organized Health Care Education/Training Program | Miami, FL | $82,136 | 38 |
| , M.D | Orthopaedic Surgery | Saint Louis, MO | $77,909 | 61 |
| , DO | Orthopaedic Surgery | Battle Creek, MI | $75,058 | 31 |
| , M.D | Orthopaedic Surgery | New York, NY | $74,778 | 40 |
| , MD | Orthopaedic Surgery | Southfield, MI | $68,428 | 48 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $19.0M
Product Information
- Type Device
- Total Payments $19.0M
- Total Doctors 1,389
- Transactions 5,542
About JOURNEY II
JOURNEY II is a device associated with $19.0M in payments to 1,389 healthcare providers, recorded across 5,542 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2020 to 2024. In 2024, $5.6M was paid across 1,832 transactions to 476 doctors.
The most common payment nature for JOURNEY II is "Royalty or License" ($12.6M, 66.7% of total).
JOURNEY II is associated with 17 research studies, including "Establishment of implant outcomes data registry" ($897,141).